Building on the success of the DREAM project, EXPLORE offers partners the opportunity to utilise MintNeuro’s neural sensing technology beyond its initial use for Drug-Resistant Epilepsy. This initiative aims to revolutionise patient outcomes across a spectrum of neurological conditions.

Neural implants are a significant medical breakthrough, providing new hope for patients with severe neurological disorders. By delivering actionable insights to physicians and enabling closed-loop treatment modalities, the integration of neural recording into existing devices represents a major advancement in neurological treatment. The EXPLORE project seeks to harness these benefits by extending access to MintNeuro’s proprietary semiconductor technology, originally developed for epilepsy monitoring, to a broader range of conditions affecting millions globally.

EXPLORE will deploy neural sensing chips across various clinical applications. Collaborating with industry partners, MintNeuro will evaluate the use of these chips in ongoing development efforts, paving the way for new collaborations and technological enhancements.

“We are expanding access to our technology to advance our partners' understanding and treatment capabilities across a broad spectrum of medical conditions,” said Jonathan Casey, VP of Quality and Operations at MintNeuro and Project Manager for EXPLORE. “EXPLORE is not just a project – it's the next step towards redefining what's possible for neural implants.”

The launch of EXPLORE is an invitation to both industry partners and investors to engage with a leading-edge technology poised for wider application. This project underscores MintNeuro's commitment to innovation and its strategic approach to market expansion and partnership.